Table of Contents Author Guidelines Submit a Manuscript
Journal of Oncology
Volume 2010, Article ID 709678, 10 pages
http://dx.doi.org/10.1155/2010/709678
Research Article

Screening for EGFR Mutations in Patients with Head and Neck Cancer Treated with Gefitinib on a Compassionate-Use Program: A Hellenic Cooperative Oncology Group Study

1GeneKOR S.A. Glyka Nera, 15354, Athens, Greece
2BioMarker Solutions, 23 Barnsbury Square, London N1 1JP, UK
3Laboratory of Molecular Oncology, Hellenic Foundation of Cancer Research, School of Medicine, Aristotle University of Thessaloniki, 54006, Thessaloniki, Greece
4ENT Department, “AHEPA” Hospital, School of Medicine, Aristotle University of Thessaloniki, 54006, Thessaloniki, Greece
51st Department of Oncology, “Metropolitan” Hospital, N. Faliro, 18547, Athens, Greece
62nd Department of Oncology, “Hygeia” Hospital, 15123, Athens, Greece
7Department of Medical Oncology, “Papageorgiou” Hospital, School of Medicine, Aristotle University of Thessaloniki , 54006, Thessaloniki, Greece

Received 24 July 2010; Revised 19 October 2010; Accepted 31 October 2010

Academic Editor: M. Roach

Copyright © 2010 Samuel Murray et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [14 citations]

The following is the list of published articles that have cited the current article.

  • Ranee Mehra, Ilya G. Serebriiskii, Roland L. Dunbrack, Matthew K. Robinson, Barbara Burtness, and Erica A. Golemis, “Protein-intrinsic and signaling network-based sources of resistance to EGFR- and ErbB family-targeted therapies in head and neck cancer,” Drug Resistance Updates, vol. 14, no. 6, pp. 260–279, 2011. View at Publisher · View at Google Scholar
  • Borivoj Vojnovic, Benjamin R. Waterhouse, Merel Gijsen, Paul R. Barber, Iain D.C. Tullis, and Anthony Kong, “Assessment of egfr/her2 dimerization by fret-flim utilizing alexa-conjugated secondary antibodies in relation to targeted therapies in cancers,” Oncotarget, vol. 2, no. 9, pp. 728–736, 2011. View at Publisher · View at Google Scholar
  • Shiang-Fu Huang, Sou-De Cheng, Huei-Tzu Chien, Chun-Ta Liao, I-How Chen, Hung-Ming Wang, Wen-Yu Chuang, Chun-Yi Wang, and Ling-Ling Hsieh, “Relationship between epidermal growth factor receptor gene copy number and protein expression in oral cavity squamous cell carcinoma,” Oral Oncology, vol. 48, no. 1, pp. 67–72, 2012. View at Publisher · View at Google Scholar
  • Shannon N. Westin, and Russell R. Broaddus, “Personalized therapy in endometrial cancer: Challenges and opportunities,” Cancer Biology & Therapy, vol. 13, no. 1, pp. 1–13, 2012. View at Publisher · View at Google Scholar
  • Carol Box, Marta Mendiola, Sharon Gowan, Gary M. Box, Melanie Valenti, Alexis De Haven Brandon, Bissan Al-Lazikani, Susanne J. Rogers, Anna Wilkins, Kevin J. Harrington, and Suzanne A. Eccles, “A novel serum protein signature associated with resistance to epidermal growth factor receptor tyrosine kinase inhibitors in head and neck squamous cell carcinoma,” European Journal of Cancer, 2013. View at Publisher · View at Google Scholar
  • Carolien Boeckx, Marc Peeters, Filip Lardon, Marc Baay, An Wouters, Pol Specenier, and Jan B. Vermorken, “Anti-Epidermal Growth Factor Receptor Therapy in Head and Neck Squamous Cell Carcinoma: Focus on Potential Molecular Mechanisms of Drug Resistance,” Oncologist, vol. 18, no. 7, pp. 850–864, 2013. View at Publisher · View at Google Scholar
  • Pablo Secades, Inés Saenz de Santa-María, Anna Merlo, Carlos Suarez, and María-Dolores Chiara, “In vitro study of normoxic epidermal growth factor receptor-induced hypoxia-inducible factor-1-alpha, vascular endothelial growth factor, and BNIP3 expression in head and neck squamous cell carcinoma cell lines: Implications for anti-epidermal growth fact,” Head & Neck, 2014. View at Publisher · View at Google Scholar
  • Jan B. Vermorken, Patrick Pauwels, Pol Specenier, Danielle Van Den Weyngaert, Carolien Boeckx, Filip Lardon, Christine Weyn, Isabelle Vanden Bempt, An Wouters, Marc Peeters, Vanessa Deschoolmeester, Carl Van Laer, Marc Baay, and Mark Kockx, “Mutation analysis of genes in the EGFR pathway in Head and Neck cancer patients: Implications for anti-EGFR treatment response,” BMC Research Notes, vol. 7, no. 1, 2014. View at Publisher · View at Google Scholar
  • Claudia Bejar, and Eve Maubec, “Therapy of Advanced Squamous Cell Carcinoma of the Skin,” Current Treatment Options in Oncology, 2014. View at Publisher · View at Google Scholar
  • Carolien Boeckx, Ken Op de Beeck, An Wouters, Vanessa Deschoolmeester, Ridha Limame, Karen Zwaenepoel, Pol Specenier, Patrick Pauwels, Jan B. Vermorken, Marc Peeters, Guy Van Camp, Marc Baay, and Filip Lardon, “Overcoming cetuximab resistance in HNSCC: The role of AURKB and DUSP proteins,” Cancer Letters, vol. 354, no. 2, pp. 365–377, 2014. View at Publisher · View at Google Scholar
  • Jun Lei, Hang Yin, Chunli Yan, Quanyong He, Bing Fu, Guanxiu Tang, and Shujuan Zhu, “Recent advance in drug development of squamous cell carcinoma,” Anti-Cancer Agents in Medicinal Chemistry, vol. 15, no. 7, pp. 816–827, 2015. View at Publisher · View at Google Scholar
  • Emily K. Kleczko, Jihye Kim, Stephen B. Keysar, Lydia R. Heasley, Justin R. Eagles, Matthew Simon, Marianne E. Marshall, Katherine R. Singleton, Antonio Jimeno, Aik-Choon Tan, and Lynn E. Heasley, “An Inducible TGF-beta 2-TGF beta R Pathway Modulates the Sensitivity of HNSCC Cells to Tyrosine Kinase Inhibitors Targeting Dominant Receptor Tyrosine,” Plos One, vol. 10, no. 5, 2015. View at Publisher · View at Google Scholar
  • Chittibabu Vatte, Amein K Al-Ali, Ali M. Al Amri, Cyril Cyrus, Sadananda Acharya, Zhara Al Ali, Shahanas Chathoth, Tariq Mohammad Hashim, Saleh Tawfeeq Alshreadah, and Ahmed Alsayyah, “Tyrosine kinase domain mutations of EGFR gene in head and neck squamous cell carcinoma,” OncoTargets and Therapy, vol. 10, pp. 1527–1533, 2017. View at Publisher · View at Google Scholar
  • Christos Perisanidis, “Prevalence of EGFR tyrosine Kinase domain mutations in head and neck squamous cell carcinoma: Cohort study and systematic review,” In Vivo, vol. 31, no. 1, pp. 23–34, 2017. View at Publisher · View at Google Scholar